PREDICTIVE ASSAYS OF RADIATION RESPONSE IN PATIENTS WITH HEAD AND NECK SQUAMOUS-CELL CARCINOMA - A REVIEW OF THE INSTITUTE-GUSTAVE-ROUSSY EXPERIENCE

Citation
F. Eschwege et al., PREDICTIVE ASSAYS OF RADIATION RESPONSE IN PATIENTS WITH HEAD AND NECK SQUAMOUS-CELL CARCINOMA - A REVIEW OF THE INSTITUTE-GUSTAVE-ROUSSY EXPERIENCE, International journal of radiation oncology, biology, physics, 39(4), 1997, pp. 849-853
Citations number
25
Categorie Soggetti
Oncology,"Radiology,Nuclear Medicine & Medical Imaging
ISSN journal
03603016
Volume
39
Issue
4
Year of publication
1997
Pages
849 - 853
Database
ISI
SICI code
0360-3016(1997)39:4<849:PAORRI>2.0.ZU;2-F
Abstract
Purpose: The aim of the study was to present the updated Institut Gust ave Roussy experience of the predictive value of three biological para meters in patients with squamous cell carcinoma of the Head and Neck ( HNSCC) treated with radiation therapy. Methods and Materials: Three pa rameters have been investigated independently: tumor cell kinetics (TS , T-pot and LI), oxygen tension measurements (PO2) and intrinsic radio sensitivity (SF(2)Gy). Results: No relationship has been found between local-regional control and T-pot or LI in a series of 74 patients, Ou r data also support that the surviving fraction at 2 Gy, (SF2) was unl ikely to predict the clinical outcome in a series of 92 patients. Diff erences in PO2 measurements have been observed between tumors, and tum or oxygenation was lower than that of normal tissue for the majority o f patient, However PO2 measurements did not predict clinical outcome, but further investigations are needed to draw definitive conclusions, given the limited number of patients entered in our study (35 patients ), In addition, we were able to measure the three parameters in 10 pat ients showing no correlation between PO2, SF2 and T-pot. Conclusions: The method used to evaluate T-pot and SF2 did not provide clinically r elevant predictive parameters for this type of cancer, Further investi gations are needed to assess the predictive value of PO2 measurements and of new biological parameters in a multiparametric approach, taking into account other possible clinical and biological confounding facto rs. (C) 1997 Elsevier Science Inc.